GlucoTrack to present first-in-human study for CBGM at 2025 conference on ATTD
people with diabetes announced that safety and performance data from its first-in-human trial of its long-term continuous blood glucose ...
Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care
GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company’s ...
News Medical17d
How accurate are continuous glucose monitors? A study puts them to the test
Other factors that can limit the accuracy of both CGM and CBGM values include inter-individual differences in the uptake and absorption of glucose after consuming a meal, blood flow differences ...
Yahoo Finance23d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
RUTHERFORD, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and ...
Morningstar23d
Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
Glucotrack’s Medical Advisory Board provides strategic guidance to Glucotrack as the Company advances development of its innovative CBGM system, which is designed to directly measure blood ...
The Globe and Mail24d
Glucotrack Commences Transition From Concept To Reality With Breakthrough Clinical Trial
The company announced the successful completion of its first human clinical trial for its Continuous Blood Glucose Monitor (CBGM), a device that could eliminate both the accuracy limitations of ...